Referred TestsFrank Cockerill, M.D., Participates in 21st Century Cures Roundtable [Updated]
Share this:
Franklin Cockerill, M.D., Chair of the Mayo Clinic Department of Laboratory Medicine and Pathology, participated in the 21st Century Cures Roundtable on Personalized Medicine hosted by the U.S. House of Representatives Energy and Commerce Committee on Wednesday, July 23.
Throughout Dr. Cockerill's remarks, he emphasized the importance of providing proper government funding for research and regulatory bodies, harmonizing regulations, emphasizing clinical validation, ensuring patient safety, and encouraging innovation. A summary of Dr. Cockerill's remarks have been embedded below.
According to the committee's website, the 21st Century Cures roundtable next brings together industry leaders to, "discuss how the rise of personalized medicine and advances in science and technology can shape the health care system in the 21st century. Specifically, the roundtable will explore how genomic sequencing and diagnostic testing, as well as the regulation of these continually evolving areas, affect innovative product development and delivery."
Video of the Roundtable
Photos
Key Points from Dr. Cockerill's Remarks
Partnerships among providers, genetic counselors & pathologists are critical to proper interpretation & application. -Cockerill #path2cures
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
Focus on harmonizing regulations, emphasizing clinical validation, ensuring patient safety & encouraging innovation. - Cockerill #path2cures
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
"Redundancy in the lab is very costly...let's save for our patients without stifling #innovation" - Dr. Cockerill #Path2Cures
— DukeMed OGR (@DukeMedOGR) July 23, 2014
Lab perspective: #personalizedmedicine means more precise clinical data to identify best treatment for a patient. -Cockerill #path2cures
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
Lab testing plays vital role in #personalizedmedicine, helping guide targeted treatments based on molecular diagnostics. #Path2Cures
— Am Clinical Lab Assn (@ACLAlabs) July 23, 2014
Dr. Cockerill delivering remarks on #personalizedmedicine at @HouseCommerce Roundtable #Path2Cures pic.twitter.com/u5ZJBRLJeQ
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
Challenges: Govt funding of scientific discovery & translating discoveries to clinical tests that benefit patients.- Cockerill #Path2Cures
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
